Amyris - a leading biotechnology company - launched a new clean skincare brand named Terasana Clinical.
The first product to drop from Terasana Clinical is the Clear + Control Healthy Skin Serum. This product is designed to moisturize dry, flaking, and irritated skin. The serum is made with anti-inflammatory properties that will help clear and even the skin's appearance. The product uses two sustainable ingredients that have been patented by Amyris - Squalane and Cannabigerol (CBG). Squalane is a clinically proven high-performing moisturizer. It helps improve the skin's microbiome and deeply penetrates cannabinoids to help enhance the skin. While Amyris' patented Cannabigerol is an anti-inflammatory and anti-microbial cannabinoid.
All ingredients found in the new Terasana Clinical line have been rigorously developed in Amyris' science and technology labs.
Hydrating Research-Backed Serums
Amyris Launches a Skincare Brand That is Expert-Approved
Trend Themes
-
Clean Skincare — The launch of Terasana Clinical presents an opportunity for clean skincare brands to focus on using sustainable and science-backed ingredients.
-
Sustainable Beauty — Amyris' use of sustainable ingredients in Terasana Clinical's serum highlights the potential for sustainable beauty to become a major trend in the industry.
-
Microbiome Skincare — The Clear + Control Healthy Skin Serum's use of Squalane to improve the skin's microbiome presents an opportunity for companies to explore microbiome skincare products.
Industry Implications
-
Biotechnology — The launch of Terasana Clinical showcases the potential for biotechnology companies to enter the skincare industry with innovative products.
-
Green Beauty — Terasana Clinical's use of sustainable and natural ingredients presents an opportunity for green beauty companies to expand their product lines.
-
CBD Skincare — Amyris' use of Cannabigerol in the Clear + Control Healthy Skin Serum indicates the potential for CBD skincare to become a disruptive innovation in the beauty industry.